Business Context and Reporting Period
Company: Achieve Life Sciences, Inc. (ACHV)
Filing Type: Form 8-K (Current Report)
Date of Report: May 13, 2021
Reporting Period: The filing announces financial results for the three months ended March 31, 2021, and reports on the Annual Meeting of Stockholders held on May 11, 2021.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Item 2.02 states that the Company issued a press release regarding these results, which is furnished as Exhibit 99.1, but the specific financial data is not included in the body of this 8-K document.
Material Changes and Corporate Actions
Annual Meeting Voting Results
The following matters were submitted to a vote of security holders on May 11, 2021:
- Election of Directors: Seven nominees were elected to serve until the next annual meeting. All nominees received significant "For" votes (ranging from approximately 1.28 million to 1.31 million) with minimal "Withhold" votes.
- Ratification of Auditors: The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021, was ratified with 3,611,908 votes "For" and 16,825 votes "Against."
Guidance, Outlook, and Risks
The filing text does not contain specific management commentary, forward-looking guidance, risk factors, or descriptions of unusual items. It serves primarily as a notification of the press release (Exhibit 99.1) and the outcome of the shareholder vote.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 13, 2021) to obtain the actual financial figures for the quarter ended March 31, 2021, as they are not listed in this summary.
- Verify the composition of the Board of Directors following the election of the seven nominees.
- Confirm the engagement of PricewaterhouseCoopers LLP for the 2021 fiscal year audit.